drugset / Trial / NCT03121664
A Study To Estimate The Effects Of Itraconazole On Pharmacokinetics Of Pf-06649751 In Healthy Adult Subjects
CrossoverOpen-labelBasic science
Summary
The purpose of this study is to evaluate the impact of CYP3A4 inhibitor, itraconazole, on plasma concentration of PF-06649751 in healthy subjects
Timeline
- Start
- 2017-04-07
- Primary completion
- 2017-09-14
- Completion
- 2017-09-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Itraconazole | Small molecule | 200 mg | — |
| Subject | Tavapadon | Small molecule | 1 mg | — |
Indications
No indication recorded.